BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sekiguchi M, Terauchi T, Kakugawa Y, Shimada N, Saito Y, Matsuda T. Performance of 18-fluoro-2-deoxyglucose positron emission tomography for esophageal cancer screening. World J Gastroenterol 2017; 23(15): 2743-2749 [PMID: 28487611 DOI: 10.3748/wjg.v23.i15.2743]
URL: https://www.wjgnet.com/1007-9327/full/v23/i15/2743.htm
Number Citing Articles
1
Brandon A. Howard, Terence Z. Wong. 18F-FDG-PET/CT Imaging for Gastrointestinal MalignanciesRadiologic Clinics of North America 2021; 59(5): 737 doi: 10.1016/j.rcl.2021.06.001
2
Hsuan-An Su, Shun-Wen Hsiao, Yu-Chun Hsu, Lien-Yen Wang, Hsu-Heng Yen. Superiority of NBI endoscopy to PET/CT scan in detecting esophageal cancer among head and neck cancer patients: a retrospective cohort analysisBMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-6558-4
3
Toshinori Iwai, Soichiro Ishikawa, Yuka Ideta, Satomi Sugiyama, Yuichiro Hayashi, Shuhei Minamiyama, Hiroaki Kitajima, Kenji Mitsudo. Limitation of PET/CT for screening of synchronous upper gastrointestinal cancer in oral cancer patientsJournal of Oral and Maxillofacial Surgery, Medicine, and Pathology 2024; 36(2): 191 doi: 10.1016/j.ajoms.2023.07.015
4
Xiao Mou, Zhenglin Peng, Tao Yin, Xingwang Sun. Non-endoscopic Screening for Esophageal Squamous Cell Carcinoma: Recent AdvancesJournal of Gastrointestinal Cancer 2023;  doi: 10.1007/s12029-023-00980-x
5
Masau Sekiguchi, Takahisa Matsuda. Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screeningScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-75319-8